Exact Therapeutics (Norway) Buy Hold or Sell Recommendation
| EXTX Stock | NOK 3.80 0.02 0.53% |
Assuming the 90 days trading horizon and your slightly conservative level of risk, our recommendation regarding Exact Therapeutics AS is 'Strong Sell'. The recommendation algorithm takes into account all of Exact Therapeutics' available fundamental, technical, and predictive indicators you will find on this site.
Check out Exact Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Exact and provide practical buy, sell, or hold advice based on investors' constraints. Exact Therapeutics AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Exact |
Execute Exact Therapeutics Buy or Sell Advice
The Exact recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Exact Therapeutics AS. Macroaxis does not own or have any residual interests in Exact Therapeutics AS or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Exact Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Exact Therapeutics Trading Alerts and Improvement Suggestions
| Exact Therapeutics generated a negative expected return over the last 90 days | |
| Exact Therapeutics has high historical volatility and very poor performance | |
| Exact Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (58.59 M) with profit before overhead, payroll, taxes, and interest of 52 K. | |
| Exact Therapeutics generates negative cash flow from operations | |
| About 64.0% of the company shares are held by company insiders |
Exact Therapeutics Returns Distribution Density
The distribution of Exact Therapeutics' historical returns is an attempt to chart the uncertainty of Exact Therapeutics' future price movements. The chart of the probability distribution of Exact Therapeutics daily returns describes the distribution of returns around its average expected value. We use Exact Therapeutics AS price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Exact Therapeutics returns is essential to provide solid investment advice for Exact Therapeutics.
| Mean Return | -0.41 | Value At Risk | -5.45 | Potential Upside | 5.45 | Standard Deviation | 5.16 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Exact Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Exact Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Exact Therapeutics or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Exact Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Exact stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.46 | |
β | Beta against Dow Jones | 0.31 | |
σ | Overall volatility | 5.24 | |
Ir | Information ratio | -0.1 |
Exact Therapeutics Volatility Alert
Exact Therapeutics AS exhibits very low volatility with skewness of -4.01 and kurtosis of 26.35. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Exact Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Exact Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Exact Therapeutics Fundamentals Vs Peers
Comparing Exact Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Exact Therapeutics' direct or indirect competition across all of the common fundamentals between Exact Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Exact Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Exact Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Exact Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Exact Therapeutics to competition |
| Fundamentals | Exact Therapeutics | Peer Average |
| Return On Equity | -0.46 | -0.31 |
| Return On Asset | -0.26 | -0.14 |
| Operating Margin | (844.98) % | (5.51) % |
| Current Valuation | 432.68 M | 16.62 B |
| Shares Outstanding | 30 M | 571.82 M |
| Shares Owned By Insiders | 64.13 % | 10.09 % |
| Shares Owned By Institutions | 26.24 % | 39.21 % |
| Price To Book | 6.55 X | 9.51 X |
| Price To Sales | 8,803 X | 11.42 X |
| Gross Profit | 52 K | 27.38 B |
| EBITDA | (56.66 M) | 3.9 B |
| Net Income | (58.59 M) | 570.98 M |
| Current Ratio | 15.66 X | 2.16 X |
| Book Value Per Share | 2.60 X | 1.93 K |
| Cash Flow From Operations | (55.11 M) | 971.22 M |
| Earnings Per Share | (1.95) X | 3.12 X |
| Number Of Employees | 8 | 18.84 K |
| Beta | 0.21 | -0.15 |
| Market Capitalization | 359.97 M | 19.03 B |
| Total Asset | 117.63 M | 29.47 B |
| Net Asset | 117.63 M |
Exact Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Exact . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 6098.96 | |||
| Daily Balance Of Power | 0.0714 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 3.86 | |||
| Day Typical Price | 3.84 | |||
| Price Action Indicator | (0.05) | |||
| Period Momentum Indicator | 0.02 |
About Exact Therapeutics Buy or Sell Advice
When is the right time to buy or sell Exact Therapeutics AS? Buying financial instruments such as Exact Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Exact Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Corona Opportunity Thematic Idea Now
Corona Opportunity
Firms that are involved in some capacity in making products or providing services to the public to buttle the virus directly or indirectly. This also includes some defencive and contrarian stocks and ETFs that are managing to avoid the big market correction coused by coronavirus. The Corona Opportunity theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Corona Opportunity Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Exact Stock
Exact Therapeutics financial ratios help investors to determine whether Exact Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Exact with respect to the benefits of owning Exact Therapeutics security.